Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-16

FDA Approved: FERABRIGHT — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FERABRIGHT (ferumoxytol) has FDA approval under its Original Application filed by Azurity Pharmaceuticals, Inc. for the treatment of iron deficiency anemia in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERABRIGHT (FERUMOXYTOL)

Snippet

ORIG AP for FERABRIGHT (FERUMOXYTOL)